Carol Gallagher

Insider Reports History

Location
C/O Atara Biotherapeutics, Inc., 3260 Bayshore Boulevard, Brisbane, CA
Signature
/s/ John Chao, Attorney-in-Fact for Carol Gallagher
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carol Gallagher:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Atara Biotherapeutics, Inc. Director Common Stock 33K $250K $7.56 Jun 10, 2025 Direct
Certara, Inc. Director Common Stock 7.06K $127K $18.00 Jun 15, 2021 Direct
PMV Pharmaceuticals, Inc. Director Stock Option (right to buy) 33.5K Jun 5, 2025 Indirect
Frazier Lifesciences Acquisition Corp Director Class B Ordinary Shares 0 Nov 22, 2022 Direct
Mirati Therapeutics, Inc. Director Common Stock 0 $59.02 Jan 23, 2024 Direct
Mirati Therapeutics, Inc. Director Option to Purchase Common Stock 0 Jan 23, 2024 Direct
PMV Pharmaceuticals, Inc. Director Stock Option (right to buy) 0 Jun 5, 2025 Direct
Turning Point Therapeutics, Inc. Director Stock Option (right to buy) 0 Aug 17, 2022 By the Gallagher Revocable Trust dated May 10, 2011
Turning Point Therapeutics, Inc. Director Stock Option (right to buy) 0 Aug 17, 2022 Direct

Insider Reports Filed by Carol Gallagher

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ATRA Atara Biotherapeutics, Inc. Jun 10, 2025 1 $0 4 Jun 12, 2025 Director
PMVP PMV Pharmaceuticals, Inc. Jun 5, 2025 3 $0 4 Jun 9, 2025 Director
PMVP PMV Pharmaceuticals, Inc. Jun 6, 2024 3 $0 4 Jun 10, 2024 Director
ATRA Atara Biotherapeutics, Inc. Mar 31, 2024 1 $0 4 Apr 2, 2024 Director
MRTX Mirati Therapeutics, Inc. Jan 23, 2024 3 $0 4 Jan 23, 2024 Director
MRTX Mirati Therapeutics, Inc. Dec 29, 2023 1 $400K 4 Jan 3, 2024 Director
ATRA Atara Biotherapeutics, Inc. Nov 13, 2023 2 $68.2K 4 Nov 15, 2023 Director
MRTX Mirati Therapeutics, Inc. Jun 22, 2023 2 $0 4 Jun 23, 2023 Director
MRTX Mirati Therapeutics, Inc. Jun 22, 2023 0 $0 3 Jun 23, 2023 Director
PMVP PMV Pharmaceuticals, Inc. Jun 8, 2023 3 $0 4 Jun 12, 2023 Director
ATRA Atara Biotherapeutics, Inc. May 31, 2023 2 $0 4 Jun 2, 2023 Director
FLAC Frazier Lifesciences Acquisition Corp Nov 22, 2022 1 $0 4 Nov 23, 2022 Director
PMVP PMV Pharmaceuticals, Inc. Nov 4, 2022 3 $0 4 Nov 8, 2022 Director
PMVP PMV Pharmaceuticals, Inc. Nov 3, 2022 0 $0 3 Nov 8, 2022 Director
TPTX Turning Point Therapeutics, Inc. Aug 17, 2022 3 $0 4 Aug 17, 2022 Director
ATRA Atara Biotherapeutics, Inc. Jun 23, 2022 2 $0 4 Jun 27, 2022 Director
CERT Certara, Inc. Jun 15, 2021 1 $0 4 Jun 16, 2021 Director
CERT Certara, Inc. Jun 15, 2021 0 $0 3 Jun 16, 2021 Director
ATRA Atara Biotherapeutics, Inc. Jun 8, 2021 2 $0 4 Jun 9, 2021 Director
TPTX Turning Point Therapeutics, Inc. Jun 2, 2021 1 $0 4 Jun 4, 2021 Director